Legal & General Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356M Buy
4,449,554
+33,585
+0.8% +$2.77M 0.08% 245
2025
Q4
$376M Buy
4,415,969
+309,200
+8% +$25.4M 0.08% 227
2025
Q3
$319M Sell
4,106,769
-117,123
-3% -$9.15M 0.07% 266
2025
Q2
$330M Sell
4,223,892
-269,910
-6% -$20.1M 0.08% 239
2025
Q1
$326M Buy
4,493,802
+273,484
+6% +$19.6M 0.09% 231
2024
Q4
$312M Sell
4,220,318
-125,636
-3% -$8.79M 0.08% 235
2024
Q3
$287M Buy
4,345,954
+45,870
+1% +$3.33M 0.08% 268
2024
Q2
$397M Sell
4,300,084
-180,335
-4% -$16M 0.11% 170
2024
Q1
$428M Sell
4,480,419
-65,858
-1% -$5.53M 0.12% 166
2023
Q4
$347M Buy
4,546,277
+6,938
+0.2% +$483K 0.11% 198
2023
Q3
$314M Sell
4,539,339
-215,084
-5% -$17.3M 0.11% 198
2023
Q2
$448M Buy
4,754,423
+116,704
+3% +$10.1M 0.15% 141
2023
Q1
$384M Buy
4,637,719
+108,521
+2% +$8.53M 0.14% 153
2022
Q4
$338M Sell
4,529,198
-237,259
-5% -$18.3M 0.13% 176
2022
Q3
$394M Sell
4,766,457
-217,735
-4% -$21M 0.15% 132
2022
Q2
$474M Buy
4,984,192
+134,421
+3% +$13.9M 0.17% 127
2022
Q1
$571M Buy
4,849,771
+372,969
+8% +$41.8M 0.17% 114
2021
Q4
$580M Sell
4,476,802
-20,109
-0.4% -$2.35M 0.18% 113
2021
Q3
$509M Buy
4,496,911
+141,877
+3% +$16.2M 0.17% 122
2021
Q2
$451M Buy
4,355,034
+226,520
+5% +$21.4M 0.15% 140
2021
Q1
$345M Sell
4,128,514
-32,598
-0.8% -$2.76M 0.13% 180
2020
Q4
$380M Sell
4,161,112
-184,882
-4% -$15.3M 0.15% 148
2020
Q3
$347M Buy
4,345,994
+124,542
+3% +$9.72M 0.16% 143
2020
Q2
$292M Buy
4,221,452
+110,714
+3% +$7.87M 0.14% 159
2020
Q1
$259M Buy
4,110,738
+138,345
+3% +$9.98M 0.15% 155
2019
Q4
$309M Buy
3,972,393
+101,028
+3% +$7.89M 0.15% 156
2019
Q3
$284M Buy
3,871,365
+4,659
+0.1% +$327K 0.15% 160
2019
Q2
$238M Sell
3,866,706
-25,224
-0.6% -$1.53M 0.13% 193
2019
Q1
$248M Buy
3,891,930
+585,669
+18% +$33.4M 0.14% 162
2018
Q4
$169M Buy
+3,306,261
New +$167M 0.13% 185
2017
Q4
Sell
-3,354,894
Closed -$122M 3287
2017
Q3
$122M Buy
3,354,894
+62,793
+2% +$2.39M 0.09% 249
2017
Q2
$130M Buy
3,292,101
+114,432
+4% +$4.18M 0.1% 223
2017
Q1
$99.6M Buy
3,177,669
+185,889
+6% +$5.82M 0.08% 264
2016
Q4
$93.4M Buy
2,991,780
+99,543
+3% +$3.23M 0.09% 255
2016
Q3
$116M Sell
2,892,237
-62,637
-2% -$2.36M 0.12% 209
2016
Q2
$98.2M Buy
2,954,874
+139,278
+5% +$4.77M 0.1% 230
2016
Q1
$82.8M Buy
2,815,596
+65,016
+2% +$1.79M 0.09% 250
2015
Q4
$72.4M Buy
2,750,580
+90,378
+3% +$2.35M 0.08% 269
2015
Q3
$63M Buy
2,660,202
+68,580
+3% +$1.66M 0.08% 287
2015
Q2
$61.5M Sell
2,591,622
-1,578
-0.1% -$35.6K 0.07% 311
2015
Q1
$61.6M Sell
2,593,200
-114,156
-4% -$2.56M 0.07% 311
2014
Q4
$57.5M Sell
2,707,356
-81,492
-3% -$1.64M 0.07% 332
2014
Q3
$47.5M Sell
2,788,848
-43,764
-2% -$691K 0.06% 378
2014
Q2
$40.5M Sell
2,832,612
-35,958
-1% -$487K 0.05% 438
2014
Q1
$35.5M Sell
2,868,570
-132,030
-4% -$1.52M 0.04% 455
2013
Q4
$32.9M Buy
3,000,600
+23,880
+0.8% +$269K 0.04% 475
2013
Q3
$34.5M Sell
2,976,720
-35,082
-1% -$410K 0.05% 449
2013
Q2
$33.7M Buy
+3,011,802
New +$35.6M 0.05% 433

Other funds holding EW